share_log
Breakings ·  Dec 9 20:00
Olema Oncology Announces FDA Clearance of Investigational New Drug Application for Op-3136, a Potent Kat6 Inhibitor
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment